Towards offline PET monitoring of proton therapy at MedAustron.


Journal

Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 04 01 2018
revised: 12 05 2018
accepted: 13 05 2018
pubmed: 3 6 2018
medline: 26 7 2019
entrez: 3 6 2018
Statut: ppublish

Résumé

The characteristic depth-dose profile of protons traveling through material is the main advantage of proton therapy over conventional radiotherapy with photons or electrons. However, uncertainties regarding the range of the protons in human tissue prevent to exploit the full potential of proton therapy. Therefore, a non-invasive in-vivo dose monitoring is desired. At the ion beam center MedAustron in Wiener Neustadt/Austria, patient treatment with proton beams started in December 2016. A PET/CT is available in close vicinity of the treatment rooms, exclusively dedicated to offline PET monitoring directly after the therapeutic irradiation. Preparations for a patient study include workflow tests under realistic clinical conditions using two different phantoms, irradiated with protons prior to the scan in the PET/CT. GATE simulations of the C-11 production are used as basis for the prediction of the PET measurement. We present results from the workflow tests in comparison with simulation results, and by this, we demonstrate the applicability of the PET monitoring at the MedAustron facility.

Identifiants

pubmed: 29858131
pii: S0939-3889(18)30001-1
doi: 10.1016/j.zemedi.2018.05.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

59-65

Informations de copyright

Copyright © 2018. Published by Elsevier GmbH.

Auteurs

Heide Meißner (H)

TU Wien, Atominstitut, Stadionallee 2, 1020 Vienna, Austria.

Hermann Fuchs (H)

Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna and Department of Radiation Therapy, Medical University of Vienna/AKH Vienna Spitalgasse 23, 1090 Vienna, Austria.

Albert Hirtl (A)

TU Wien, Atominstitut, Stadionallee 2, 1020 Vienna, Austria.

Christian Reschl (C)

EBG MedAustron GmbH, Marie-Curie-Straße 5, 2700 Wiener Neustadt, Austria.

Markus Stock (M)

EBG MedAustron GmbH, Marie-Curie-Straße 5, 2700 Wiener Neustadt, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH